BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35776191)

  • 21. Identification of a novel PHIP::BRAF gene fusion in infantile fibrosarcoma.
    Boulouadnine B; de Villenfagne L; Galant C; Sciot R; Brichard B; Demoulin JB
    Genes Chromosomes Cancer; 2022 Nov; 61(11):678-682. PubMed ID: 35672277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.
    Green BL; Grant RRC; Richie CT; Chatterjee B; Sampaio De Melo M; Barr FG; Pacak K; Agarwal SK; Nilubol N
    Eur J Endocrinol; 2022 Jul; 187(1):185-196. PubMed ID: 35861986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.
    Lee NV; Lira ME; Pavlicek A; Ye J; Buckman D; Bagrodia S; Srinivasa SP; Zhao Y; Aparicio S; Rejto PA; Christensen JG; Ching KA
    PLoS One; 2012; 7(6):e39653. PubMed ID: 22745804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing for
    Le Flahec G; Briolais M; Guibourg B; Lemasson G; Grippari JL; Ledé F; Marcorelles P; Uguen A
    J Clin Pathol; 2020 Feb; 73(2):116-119. PubMed ID: 31506288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
    Wang L; Basturk O; Wang J; Benayed R; Middha S; Zehir A; Linkov I; Rao M; Aryeequaye R; Cao L; Chmielecki J; Ross J; Stephens PJ; Adsay V; Askan G; Balci S; Klimstra DS
    Mod Pathol; 2018 Jan; 31(1):132-140. PubMed ID: 28884748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
    Wang J; Li R; Li J; Yi Y; Liu X; Chen J; Zhang H; Lu J; Li C; Wu H; Liang Z
    J Transl Med; 2021 Oct; 19(1):433. PubMed ID: 34657620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
    Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.
    Mehrotra A; Saladi SV; Trivedi AR; Aras S; Qi H; Jayanthy A; Setaluri V; de la Serna IL
    Arch Biochem Biophys; 2014 Dec; 563():125-35. PubMed ID: 25026375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genetic landscape of ganglioglioma.
    Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA
    Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.
    Katschnig AM; Kauer MO; Schwentner R; Tomazou EM; Mutz CN; Linder M; Sibilia M; Alonso J; Aryee DNT; Kovar H
    Oncogene; 2017 Oct; 36(43):5995-6005. PubMed ID: 28671673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid schwannoma-perineurioma frequently harbors VGLL3 rearrangement.
    Dickson BC; Antonescu CR; Demicco EG; Leong DI; Anderson ND; Swanson D; Zhang L; Fletcher CDM; Hornick JL
    Mod Pathol; 2021 Jun; 34(6):1116-1124. PubMed ID: 33649458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
    Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
    Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1.
    Mori S; Takeuchi T; Ishii Y; Kukimoto I
    J Virol; 2020 May; 94(10):. PubMed ID: 32132238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
    Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J
    Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin.
    Landin Malt A; Cagliero J; Legent K; Silber J; Zider A; Flagiello D
    PLoS One; 2012; 7(9):e45498. PubMed ID: 23029054
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 39. RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling.
    Choi S; Lee HS; Cho N; Kim I; Cheon S; Park C; Kim EM; Kim W; Kim KK
    Nucleic Acids Res; 2022 Aug; 50(15):8658-8673. PubMed ID: 35699208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.